Biotech companies are seeing significant pre-market activity this Monday, hinting at possible breakout opportunities.
Assessing sentiment and momentum in the premarket sets the tone for a trader's day.
Price swings ahead of the opening bell are being driven by positive clinical trial data, agreements, financing deals, and corporate restructuring announcements.
In the Green - Premarket Gainers
On Monday, the following stocks were trading significantly higher in the pre-market session.
1. Tango Therapeutics, Inc. (TNGX) - up 45% at $29.272. WORK Medical Technology Group LTD. (WOK) - up 19% at $0.103. Nurix Therapeutics, Inc. (NRIX) - up 13% at $16.504. Eledon Pharmaceuticals, Inc. (ELDN) - up 10% at $3.745. Cardio Diagnostics Holdings, Inc. (CDIO) - up 9% at $2.136. Aldeyra Therapeutics, Inc. (ALDX) - up 9% at $1.777. RenovoRx, Inc. (RNXT) - up 9% at $0.948. Cullinan Therapeutics, Inc. (CGEM) - up 8% at $14.659. Werewolf Therapeutics, Inc. (HOWL) - up 7% at $0.4210. China Pharma Holdings, Inc. (CPHI) - up 5% at $0.75
In the Red - Premarket Losers
The following stocks were trading lower in the premarket session on Monday.
1. GoHealth, Inc. (GOCO) - down 38% at $0.422. Clearmind Medicine Inc. (CMND) - down 21% at $3.153. Aditxt, Inc. (ADTX) - down 19% at $0.054. Nuwellis, Inc. (NUWE) - down 17% at $0.135. SciSparc Ltd. (SPRC) - down 15% at $9.686. Vivos Therapeutics, Inc. (VVOS) - down 10% at $0.787. Apimeds Pharmaceuticals US, Inc. (APUS) -down 9% at $1.158. InMed Pharmaceuticals Inc. (INM) - down 7% at $1.479. Virax Biolabs Group Limited. (VRAX) - down 7% at $0.1910. BioCardia, Inc. (BCDA) - down 4% at $0.98
For More Such Biotech Stock News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.